Product Information
PRISTIQ ER 100 MG TABLET is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $13.9394 per EA under NDC 00008122214. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Feb 29, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the desvenlafaxine succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
NDC
00008122214
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DESVENLAFAXINE SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA021992FDA Approved
2/29/2008
TE Code
AB
On Market Since
5/1/2008
Pharmacological Classes
Price Statistics
The NADAC for PRISTIQ ER 100 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 141.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.9394 per EA |
|---|---|
| All-time high | $13.9802 (Aug 14, 2024) |
| All-time low | $5.7826 (Nov 28, 2013) |
| 52-week high | $13.9681 |
| 52-week low | $13.9365 |
| Median price | $13.2386 |
| Average price | $11.9033 |
| Largest weekly change | +9.7% (Jan 8, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRISTIQ ER 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRISTIQ ER 100 MG TABLET, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $13.9394 per EA (NDC 00008122214), effective Aug 19, 2026.
How has the price of PRISTIQ ER 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRISTIQ ER 100 MG TABLET has risen 141.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PRISTIQ ER 100 MG TABLET?
Since Nov 28, 2013, the NADAC for PRISTIQ ER 100 MG TABLET has ranged from a low of $5.7826 (Nov 28, 2013) to a high of $13.9802 (Aug 14, 2024), with a median of $13.2386 per EA.
Are there cheaper alternatives to PRISTIQ ER 100 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRISTIQ ER 100 MG TABLET, is $12.8531 per EA — about 8% below PRISTIQ ER 100 MG TABLET.
Who manufactures PRISTIQ ER 100 MG TABLET?
PRISTIQ ER 100 MG TABLET (NDC 00008122214) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.